Search
for
Sort by
Research 601–630 of 1000+
- The expression of the gene <i>asebia</i> in the laboratory mouse: 3. Sebaceous glands
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- The Rotterdam Study: 2016 objectives and design update
- Androgens and hair: a biological paradox
- Clinical use of 5α-reductase inhibitors
- Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis
- Androgens/Androgen Receptor in the Management of Skin Diseases
- Replacement with GABAergic steroid precursors restores the acute ethanol withdrawal profile in adrenalectomy/gonadectomy mice
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome
- The Role of Probiotics and Synbiotics on Hirsutism
- Serum prolactin and dehydroepiandrosterone concentrations during the summer and winter hair growth cycles of mink (Mustela vison)
- Late bedtime was associated with increased androgen and reduced lean mass in women with polycystic ovary syndrome: a cross-sectional study
- Polycystic ovary syndrome
- Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
- Current understanding and treatment of sex hormone-related hair diseases
- Steroid Sulfatase Deficiency and Androgen Activation Before and After Puberty
- Effects of Acanthus ebracteatus Vahl. extract and verbascoside on human dermal papilla and murine macrophage
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Short‐Term, Low‐Dose Spironolactone for Treatment of Hyperandrogenic Symptoms of Polycystic Ovary Syndrome—A Systematic Review
- 5α-Reductase Type 2 Regulates Glucocorticoid Action and Metabolic Phenotype in Human Hepatocytes
- Pathophysiology of the Behçet's Disease
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Treatment guidelines in adult women
- Steroid Hormones of Reproduction and Sexual Development
- Chapter 23. Therapeutic Control of Androgen Action
- Antiandrogen Therapy for Skin and Hair Disease
- Therapeutic options in the polycystic ovary syndrome